Cardiomyopathy in a patient with Duchenne dystrophy
Authors:
Company:
1 Pirogov Russian National Research Medical University, Moscow, Russian Federation
2 City Clinical Hospital № 31 named after G.M. Savelieva, Moscow, Russian Federation
For correspondence: Sign in or register.
Type: Case reports
DOI:
For citation: Reznik E.V., Khachirova E.А., Iarovoi M.D., Golukhov G.N. Cardiomyopathy in a patient with Duchenne dystrophy. Creative Cardiology. 2025; 19 (2): 241–248 (in Russ.). DOI: 10.24022/1997-3187-2025-19-2-241-248
Received / Accepted: 17.03.2025 / 27.03.2025
Keywords: Duchenne dystrophy cardiomyopathy creatine phosphokinase dystrophin
Abstract
Progressive Duchenne muscular dystrophy is a genetic disease with an incidence rate of 1:5000 in males. It occurs as a result of a mutation in the Duchenne muscular dystrophy gene, responsible for the synthesis of the dystrophin protein, which is most often localized in skeletal muscles and myocardium. Cardiological manifestations of this disease include progressive hypertrophic and dilated cardiomyopathy, as well as various arrhythmias that can lead to death. Echocardiography and electrocardiography are used as diagnostic methods for cardiac manifestations of progressive Duchenne muscular dystrophy; fewer sensitive methods include determining the level of creatine phosphokinase, troponin I and other laboratory parameters. Our work describes a clinical case of a patient with a confirmed diagnosis of progressive Duchenne dystrophy and diagnosed cardiomyopathy at the age of 15 years. The disease is progressive in nature with an unfavorable prognosis.References
- Clinical guidelines of the Ministry of Health of the Russian Federation. Progressive Duchenne muscular dystrophy. Becker’s progressive muscular dystrophy, 2023. https://dmd-russia.ru/wp-content/uploads/2023/12/klinicheskie_rekomendatsii.pdf (Accessed 12.02.2025)
- Petrof B.J., Shrager J.B., Stedman H.H., Kelly A.M., Sweeney H.L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA. 1993; 90 (8): 3710–3714. DOI: 10.1073/pnas.90.8.3710
- Wallace G.Q., McNally E.M. Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies. Annu Rev. Physiol. 2009; 71: 37–57. DOI: 10.1146/annurev.physiol.010908.163216
- Kamdar F., Garry D.J. Dystrophin-deficient cardiomyopathy. J. Am. Coll. Cardiol. 2016; 67: 2533–2546.
- Aartsma-Rus A., Van Deutekom J.C., Fokkema I.F., Van Ommen G.J., Den Dunnen J.T. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve. 2006; 34 (2): 135–144. DOI: 10.1002/mus.20586
- Magri F., Govoni A., D’Angelo M.G., Del Bo R., Ghezzi S., Sandra G. et al. Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up. J. Neurol. 2011; 258 (9): 1610–1623. DOI: 10.1007/s00415-011-5979-z
- Gaynetdinova D.D., Novoselova A.A. Current diagnosis and treatment of Duchenne muscular dystrophy. Kazan Medical Journal. 2020; 101 (4): 530–537 (in Russ.). DOI: 10.17816/KMJ2020-530
- Groznova O.S., Rudenskaya G.E., Adyan T.A., Kharlamov D.A. Cardiac lesion in children with inherited neuromuscular diseases. Russian Bulletin of Perinatology and Pediatrics. 2014; 59 (2): 35–42 (in Russ.).
- Ervasti J.M., Ohlendieck K., Kahl S.D., Gaver M.G., Campbell K.P. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature. 1990; 345 (6273): 315–319. DOI: 10.1038/345315a0
- Franco A. Jr, Lansman J.B. Calcium entry through stretch-inactivated ion channels in mdx myotubes. Nature. 1990; 344 (6267): 670–673. DOI: 10.1038/344670a0
- Gandhi S., Sweeney H.L., Hart C.C., Han R., Perry C.G.R. Cardiomyopathy in Duchenne muscular dystrophy and the potential for mitochondrial therapeutics to improve treatment response. Cells. 2024; 13 (14): 1168. DOI: 10.3390/cells13141168
- Spurney C.F., Ascheim D., Charnas L., Cripe L., Hor K., King N. et al. Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel. Open Heart. 2021; 8 (1): e001592. DOI: 10.1136/openhrt-2021-001592
- Yanagisawa A., Yokota N., Miyagawa M., Kawamura J., Ishihara T., Aoyagi T., Ishikawa K. Plasma levels of atrial natriuretic peptide in patients with Duchenne’s progressive muscular dystrophy. Am. Heart J. 1990; 120 (5): 1154–1158. DOI: 10.1016/0002-8703(90)90130-p
- Spurney C., Shimizu R., Morgenroth L.P., Kolski H., Gordish-Dressman H., Clemens P.R.; CINRG Investigators. Cooperative International Neuromuscular Research Group Duchenne Natural History Study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy. Muscle Nerve. 2014; 50 (2): 250–256. DOI: 10.1002/mus.24163
- Giatrakos N., Kinali M., Stephens D., Dawson D., Muntoni F., Nihoyannopoulos P. Cardiac tissue velocities and strain rate in the early detection of myocardial dysfunction of asymptomatic boys with Duchenne’s muscular dystrophy: relationship to clinical outcome. >Heart. 2006; 92 (6): 840–842. DOI:
- Tang L., Shao S., Wang C. Electrocardiographic features of children with Duchenne muscular dystrophy. Orphanet. J. Rare Dis. 2022; 17: 320. DOI: 10.1186/s13023-022-02473-9
- Zhou J., Wang Ch. Electrocardiographic features of children with Duchenne muscular dystrophy and genotype analysis. J. Precis. Med. 2018; 33 (04): 300–303.
- Shah A.M., Jefferies J.L., Rossano J.W., Decker J.A., Cannon B.C., Kim J.J. Electrocardiographic abnormalities and arrhythmias are strongly associated with the development of cardiomyopathy in muscular dystrophy. Heart Rhythm. 2010; 7 (10): 1484–1488. DOI: 10.1016/j.hrthm.2010.06.022
- Connuck D.M., Sleeper L.A., Colan S.D., Cox G.F., Towbin J.A., Lowe A.M. et al. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am. Heart J. 2008; 155: 998–1005.
- Rose E.A., Gelijns A.C., Moskowitz A.J., Heitjan D.F., Stevenson L.W., Dembitsky W. et al. Long-term use of a left ventricular assist device. N. Engl. J. Med. 2001; 345: 1435–1443.
- Dubinin M.V., Starinets V.S., Chelyadnikova Y.A., Belosludtseva N.V., Mikheeva I.B., Penkina D.K. et al. Effect of large-conductance calcium-dependent K+ channel activator NS1619 on function of mitochondria in the heart of dystrophin-deficient mice. Biochemistry (Mosc.). 2023; 88 (2): 189–201. DOI: 10.1134/S0006297923020037
- Nigro G., Comi L.I., Limongelli F.M., Giugliano M.A., Politano L., Petretta V. et al. Prospective study of X-linked progressive muscular dystrophy in Campania. Muscle Nerve. 1983; 6 (4): 253–262. DOI: 10.1002/mus.880060403
- Boeva O.I., Shcheglova E.V., Bulgakova N.E., Yagoda A.V. A case of dilated cardiomyopathy in a patient with a hereditary disease – progressive Duchenne–Becker muscular dystrophy. Medical Bulletin of the North Caucasus. 2013; 8 (1): 104–108 (in Russ.).
- Greiner E., Ikeda N., Ryan T.D., Villa C.R. Hypertrophic cardiomyopathy in Duchenne muscular dystrophy: a case series. Cardiol. Young. 2024; 34 (10): 2272–2274. DOI: 10.1017/S1047951124026659
About Authors
- Elena V. Reznik, Dr. Med. Sci., Associate Professor, Head of the Department of Internal Disease Propedeutics № 2, Terapevt, Cardiologist, Functional Diagnostician, Physician of Ultrasonic Diagnostics, Clinical Pharmacologist; ORCID
- Elvira A. Khachirova, Cand. Med. Sci., Associate Professor; ORCID
- Maksim D. Iarovoi, Student; ORCID
- Georgy N. Golukhov, Dr. Med. Sci., Corresponding Member of the Russian Academy of Sciences; ORCID